By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

EnGeneIC Pty Ltd 

105 Delhi Road, North Ryde

Sydney  New South Wales  2113  Australia
Phone: 612-9878-5456 Fax: 612-9878-5922


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
EnGeneIC Pty Ltd Announces Publication In The Lancet Oncology Of First Clinical Study Employing EDV Nanocell Platform to Enable microRNA Replacement Therapy 9/5/2017 8:34:45 AM
EnGeneIC Pty Ltd Doses First Patient In U.S. Phase 1 Clinical Study Of Targeted EDV Nanocells In Recurrent Glioblastoma Multiforme 3/21/2017 6:31:25 AM
EnGeneIC Pty Ltd Receives FDA Orphan Drug Designation For Targeted EDV Nanocells To Treat Glioblastoma Multiforme 3/2/2017 6:38:43 AM
EnGeneIC Pty Ltd Enters Into Research Collaboration With Takeda (TKPYY) To Develop EDV-Based Immunomodulatory Therapies For Oncology 10/10/2016 7:30:36 AM
EnGeneIC Pty Ltd's Joint-CEO And Co-Founder, Jennifer Macdiarmid, Ph.D., Recognized In Innovation Category In The Australian Financial Review And Westpac 100 Women Of Influence Awards For 2016 10/4/2016 8:44:38 AM
EnGeneIC Pty Ltd Named One Of Science Meets Business Top 25 Australian Research And Development Spin-Off Companies 3/10/2016 9:17:39 AM
EnGeneIC Pty Ltd To Present At BIO CEO & Investor Conference 2016 2/3/2016 9:35:54 AM
EnGeneIC Pty Ltd Strengthens Board Of Directors To Support U.S. Expansion 1/25/2016 6:36:52 AM
EnGeneIC Pty Ltd To Present At The Stifel 2015 Healthcare Conference 11/11/2015 12:57:04 PM
EnGeneIC Pty Ltd To Initiate U.S. Phase 1 Clinical Study Using Targeted EDV Nanocells To Treat Advanced Glioma Patients 9/16/2015 7:32:07 AM
12
//-->